Jan Studnička

810 total citations
65 papers, 533 citations indexed

About

Jan Studnička is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Jan Studnička has authored 65 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Ophthalmology, 29 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in Jan Studnička's work include Retinal Diseases and Treatments (39 papers), Retinal Imaging and Analysis (25 papers) and Retinal and Optic Conditions (19 papers). Jan Studnička is often cited by papers focused on Retinal Diseases and Treatments (39 papers), Retinal Imaging and Analysis (25 papers) and Retinal and Optic Conditions (19 papers). Jan Studnička collaborates with scholars based in Czechia, United States and Hungary. Jan Studnička's co-authors include H Langrová, E Rencová, Andreas Wenzel, M. Bláha, Katja Hatz, Miroslav Veith, Sajjad Mahmood, Federico Ricci, João Figueira and Vladimir Bezlyak and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Pharmacology & Therapeutics.

In The Last Decade

Jan Studnička

57 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Studnička Czechia 12 359 286 67 58 32 65 533
Manishi Desai United States 14 401 1.1× 269 0.9× 16 0.2× 44 0.8× 15 0.5× 38 685
Brian T. Soetikno United States 19 612 1.7× 570 2.0× 10 0.1× 151 2.6× 22 0.7× 40 1.1k
Zuohong Li China 16 157 0.4× 81 0.3× 26 0.4× 134 2.3× 16 0.5× 56 697
Hunter L. Little United States 17 572 1.6× 295 1.0× 8 0.1× 114 2.0× 27 0.8× 33 811
Adem Türk Türkiye 12 339 0.9× 273 1.0× 25 0.4× 44 0.8× 16 0.5× 50 541
Harriet O. Lloyd United States 18 470 1.3× 585 2.0× 5 0.1× 51 0.9× 11 0.3× 37 862
Ch. Ulrich Germany 10 95 0.3× 238 0.8× 7 0.1× 46 0.8× 9 0.3× 27 445
Francis A. L'Espérance United States 17 517 1.4× 549 1.9× 4 0.1× 67 1.2× 14 0.4× 37 777
Manju L. Subramanian United States 14 484 1.3× 325 1.1× 6 0.1× 99 1.7× 27 0.8× 57 618

Countries citing papers authored by Jan Studnička

Since Specialization
Citations

This map shows the geographic impact of Jan Studnička's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Studnička with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Studnička more than expected).

Fields of papers citing papers by Jan Studnička

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Studnička. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Studnička. The network helps show where Jan Studnička may publish in the future.

Co-authorship network of co-authors of Jan Studnička

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Studnička. A scholar is included among the top collaborators of Jan Studnička based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Studnička. Jan Studnička is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bláha, V., Jana Rathouska, H Langrová, et al.. (2024). Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration. Scientific Reports. 14(1). 28902–28902. 1 indexed citations
2.
Studnička, Jan, et al.. (2024). Retinal Vein Occlusion Guidelines. PubMed. 80(6). 296–303. 3 indexed citations
3.
Woo, Se Joon, Attila Vajas, Min Sagong, et al.. (2023). Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology. 141(7). 668–668. 20 indexed citations
4.
Studnička, Jan, et al.. (2023). Diabetic Retinopathy – Diagnostics and Treatment Guidelines. 79(5). 238–247. 1 indexed citations
5.
Langrová, H, et al.. (2023). Rheohemapheresis in the Treatment of Dry Form of AMD. A Case Report. PubMed. 79(1). 42–46. 1 indexed citations
6.
Ernest, Jan, et al.. (2023). Diabetic Macular Edema – Diagnostics and Treatment Guidelines. PubMed. 79(5). 225–235. 2 indexed citations
7.
Bláha, V., et al.. (2023). Rheopheresis in the Treatment of Age-Related Macular Degeneration. PubMed. 79(1). 8–24. 1 indexed citations
8.
Hosák, Ladislav, et al.. (2023). Retinal microvascular abnormalities in major depression. Biomedical Papers. 168(2). 147–155.
9.
Bressler, Neil M., Miroslav Veith, Jan Ernest, et al.. (2021). Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes. British Journal of Ophthalmology. 107(3). 384–391. 26 indexed citations
10.
Studnička, Jan, et al.. (2019). Use of anti‑VEGF drugs in ophthalmology. 33(1). 19–24. 1 indexed citations
11.
Studnička, Jan, et al.. (2019). The Interface Between Psychiatry and Ophthalmology. Acta Medica (Hradec Kralove Czech Republic). 62(2). 45–51. 4 indexed citations
13.
Jarkovský, Jiří, Jan Studnička, Martin Šín, et al.. (2015). The efficacy of ranibizumab treatment in clinical practice in patients with the wet form of age-related macular degeneration. The results of the Czech National Registry. Biomedical Papers. 159(3). 407–412. 2 indexed citations
14.
Bláha, M., E Rencová, H Langrová, et al.. (2013). Rheohaemapheresis in the treatment of nonvascular age-related macular degeneration. Atherosclerosis Supplements. 14(1). 179–184. 21 indexed citations
15.
Studnička, Jan, E Rencová, P Rozsíval, et al.. (2012). Effects of treatment change in patients with neovascular age-related macular degeneration; Results from the Czech National Registry. Biomedical Papers. 156(4). 359–364. 1 indexed citations
16.
Nofziger, Charity, Valeria Vezzoli, Silvia Dossena, et al.. (2011). STAT6 Links IL-4/IL-13 Stimulation With Pendrin Expression in Asthma and Chronic Obstructive Pulmonary Disease. Clinical Pharmacology & Therapeutics. 90(3). 399–405. 48 indexed citations
17.
Rencová, E, M. Bláha, Jan Studnička, et al.. (2010). Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form. Acta Ophthalmologica. 89(5). 463–471. 19 indexed citations
18.
Melichar, Bohuslav, et al.. (2008). Mélanome malin de la conjonctive associé à deux autres lésions malignes primitives. Journal Français d Ophtalmologie. 31(2). 184.e1–184.e4. 3 indexed citations
19.
Fischer, S., V. Veselý, M. Šı́cha, et al.. (1974). Charged particle measurements on board the Intercosmos 5 satellite made by the PG-1-A apparatus. Bulletin of the Astronomical Institutes of Czechoslovakia. 25. 69. 1 indexed citations
20.
Studnička, Jan. (1965). Measurement of stationary striations by a microwave method. British Journal of Applied Physics. 16(11). 1739–1746. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026